OGN antibody (C-Term)
Quick Overview for OGN antibody (C-Term) (ABIN7218124)
Target
See all OGN AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- Osteoglycin Polyclonal Antibody
-
Specificity
- Osteoglycin Polyclonal Antibody detects endogenous levels of Osteoglycin protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
Immunogen
- Synthesized peptide derived from the C-terminal region of human Osteoglycin
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:20000). Not yet tested in other applications.
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- OGN (Osteoglycin (OGN))
-
Alternative Name
- Osteoglycin
-
Background
- Rabbit Anti-Osteoglycin Polyclonal Antibody,OGN, OIF, SLRR3A, Mimecan, Osteoglycin, Osteoinductive factor, OIF,OGN encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The osteoglycin induces ectopic bone formation in conjunction with transforming growth factor beta and may regulate osteoblast differentiation. High expression of the encoded protein may be associated with elevated heart left ventricular mass. Alternative splicing results in multiple transcript variants.,Mimecan
-
Molecular Weight
- observerd band 35kDa
-
Gene ID
- 4969
-
UniProt
- P20774
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-